Actavis is nearing a takeover deal for Allergan that could swipe the Botox maker from its hostile suitor, Valeant Pharmaceuticals International.
WSJ.com: Europe Home, Wall Street Journal: World: Home Europe
Sun, 11/16/2014 - 1:14pm
Actavis is nearing a takeover deal for Allergan that could swipe the Botox maker from its hostile suitor, Valeant Pharmaceuticals International.